Page last updated: 2024-09-05

enzastaurin and niacinamide

enzastaurin has been researched along with niacinamide in 2 studies

Compound Research Comparison

Studies
(enzastaurin)
Trials
(enzastaurin)
Recent Studies (post-2010)
(enzastaurin)
Studies
(niacinamide)
Trials
(niacinamide)
Recent Studies (post-2010) (niacinamide)
188529913,3811,0975,797

Protein Interaction Comparison

ProteinTaxonomyenzastaurin (IC50)niacinamide (IC50)
Chain A, NAD-dependent deacetylaseThermotoga maritima1000
Fatty-acid amide hydrolase 1Rattus norvegicus (Norway rat)3.3
NAD-dependent protein deacetylase sirtuin-2Homo sapiens (human)2.9
NAD-dependent protein deacetylase sirtuin-3, mitochondrialHomo sapiens (human)8.1

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berger, W; Lamm, W; Micksche, M; Pichelmeyer, O; Pirker, C; Schmidinger, M; Vogl, UM; Zielinski, CC1
Anderson, KC; Podar, K1

Reviews

1 review(s) available for enzastaurin and niacinamide

ArticleYear
Emerging therapies targeting tumor vasculature in multiple myeloma and other hematologic and solid malignancies.
    Current cancer drug targets, 2011, Volume: 11, Issue:9

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Benzenesulfonates; Hematologic Neoplasms; Humans; Indoles; Multiple Myeloma; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Phthalazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Sorafenib; Sunitinib; Thalidomide; Vascular Endothelial Growth Factor A; Wnt Signaling Pathway

2011

Other Studies

1 other study(ies) available for enzastaurin and niacinamide

ArticleYear
Synergistic effect of Sorafenib and Sunitinib with Enzastaurin, a selective protein kinase C inhibitor in renal cell carcinoma cell lines.
    Cancer letters, 2009, May-18, Volume: 277, Issue:2

    Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Niacinamide; Phenylurea Compounds; Protein Kinase C; Protein Kinase C beta; Pyridines; Pyrroles; Ribosomal Protein S6 Kinases; Signal Transduction; Sorafenib; Sunitinib

2009